/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Arena Pharmaceuticals Inc.\n \n\n\n\n\n
Nov 22 3:23 PM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Nov 18, 2009 6:52 AM EST
\n\n \n StockPreacher.com Issues Trading Outlook for Arena Pharmaceuticals Inc. - GlobeNewswire\n \n \n
\n\n Nov 13, 2009 6:49 AM EST
\n\n \n RidgewaterEquity.com Free Fundamental Sector & Market Research on SWHC, RVBD, SYNA, ARNA, CIEN and ATVI - Marketwire\n \n \n
\n\n Nov 09, 2009 7:07 PM EST
\n\n \n Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments - PR Newswire\n \n \n
\n\n Nov 04, 2009 4:08 PM EST
\n\n \n Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, November 10, 2009 - PR Newswire\n \n \n
\n\n Nov 04, 2009 5:30 AM EST
\n\n \n Unbiased Analysis on PHM, PPL, RT, RAD, ARNA and GNVC Posted on WallStSense.com - Marketwire\n \n \n
\n\n Nov 03, 2009 5:00 PM EST
\n\n \n Zacks Analyst Blog Highlights: Clorox Company, Arena Pharmaceuticals, Vivus Inc., Orexigen Therapeutics and Amylin Pharmaceuticals - Business Wire\n \n \n
\n\n Oct 27, 2009 10:40 AM EDT
\n\n \n New Data From Arena Pharmaceuticals' Pivotal BLOSSOM Trial of Lorcaserin Demonstrate Improvements in Patients' Body Composition, Cardiovascular Risk Factors and Quality of Life - PR Newswire\n \n \n
\n
\n\n");